Drug-screening in AML at Relapse for Targeted Treatment
NCT05732688
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
AML
Interventions
DIAGNOSTIC_TEST:
Image-based ex-vivo drug screening platform (pharmacoscopy)
Sponsor
Insel Gruppe AG, University Hospital Bern